glp 1 surgery and Bariatric surgery and medications called GLP-1s (glucagon-like peptide-1 receptor GLP-1s Vs. Bariatric Surgery For

Description

In conclusion, GLP-1 receptor agonists are medications with a single mechanism of action, that is, they activate GLP-1 receptors at various organs, all of which contribute to weight loss

Secondly, GLP-1 receptor agonists carry important safety considerations including risk of pancreatitis, gallbladder disease, and potential thyroid C-cell tumours (based on rodent studies, though human relevance remains uncertain)

Current medications: A list of other medications being taken, to ensure there are no interactions and that the GLP-1 therapy is the most appropriate option

Semaglutide and Tirzepatide help reduce systemic inflammation, which can ease joint pain, support thyroid function, and even improve mood and energy

Boxed Warning (Thyroid C-Cell Tumor Risk) GLP-1 receptor agonists, including semaglutide, carry an FDA boxed warning regarding the potential risk of thyroid C-cell tumors